Inspire Medical Systems, Inc. – NYSE:INSP

Inspire Medical Systems stock price today

$90.06
-98.41
-52.22%
Financial Health
0
1
2
3
4
5
6
7
8
9

Inspire Medical Systems stock price monthly change

+35.70%
month

Inspire Medical Systems stock price quarterly change

+35.70%
quarter

Inspire Medical Systems stock price yearly change

-7.37%
year

Inspire Medical Systems key metrics

Market Cap
5.39B
Enterprise value
6.50B
P/E
-146.29
EV/Sales
24.10
EV/EBITDA
-145.96
Price/Sales
25.71
Price/Book
13.99
PEG ratio
37.53
EPS
-0.54
Revenue
660.91M
EBITDA
-23.12M
Income
-15.73M
Revenue Q/Q
28.23%
Revenue Y/Y
41.71%
Profit margin
-17.79%
Oper. margin
-17.51%
Gross margin
83.71%
EBIT margin
-17.51%
EBITDA margin
-3.5%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Inspire Medical Systems stock price history

Inspire Medical Systems stock forecast

Inspire Medical Systems financial statements

Average Price Target
Last Year

$250.67

Potential upside: 178.33%

Based on estimate of 2 analysts
  • Analysts Price target

  • Financials & Ratios estimates

Inspire Medical Systems, Inc. (NYSE:INSP): Profit margin
Jun 2023 151.09M -11.95M -7.91%
Sep 2023 153.30M -8.54M -5.57%
Dec 2023 192.50M 14.76M 7.67%
Mar 2024 164.01M -10.00M -6.1%
Inspire Medical Systems, Inc. (NYSE:INSP): Debt to assets
Jun 2023 618246000 88.88M 14.38%
Sep 2023 639494000 95.31M 14.9%
Dec 2023 676811000 104.29M 15.41%
Mar 2024 685842000 96.81M 14.12%
Inspire Medical Systems, Inc. (NYSE:INSP): Cash Flow
Jun 2023 5.09M 4.89M 14.93M
Sep 2023 3.63M -144.24M 3.5M
Dec 2023 17.26M -151.72M -10.11M
Mar 2024 8.86M -19.53M 768K

Inspire Medical Systems alternative data

Inspire Medical Systems, Inc. (NYSE:INSP): Employee count
Sep 2023 755
Oct 2023 755
Nov 2023 755
Dec 2023 755
Jan 2024 755
Feb 2024 755
Mar 2024 1,011
Apr 2024 1,011
May 2024 1,011
Jun 2024 1,011
Jul 2024 1,011

Inspire Medical Systems other data

56.40% -43.57%
of INSP is owned by hedge funds
15.83M -12.38M
shares is hold by hedge funds

Inspire Medical Systems, Inc. (NYSE:INSP): Insider trades (number of shares)
Period Buy Sel
Feb 2024 0 23895
Mar 2024 0 6603
Apr 2024 0 55032
Aug 2024 0 26000
Sep 2024 0 831
Nov 2024 0 8703
Transaction Date Insider Security Shares Price per share Total value Source
Option
RONDONI JOHN officer: Chief Technology Officer
Common Stock 2,901 $42.15 $122,277
Option
RONDONI JOHN officer: Chief Technology Officer
Common Stock 5,802 $71 $411,942
Sale
RONDONI JOHN officer: Chief Technology Officer
Common Stock 5,777 $192.93 $1,114,557
Sale
RONDONI JOHN officer: Chief Technology Officer
Common Stock 1,580 $193.92 $306,394
Sale
RONDONI JOHN officer: Chief Technology Officer
Common Stock 1,013 $194.84 $197,373
Sale
RONDONI JOHN officer: Chief Technology Officer
Common Stock 333 $196.42 $65,408
Option
RONDONI JOHN officer: Chief Technology Officer
Employee Stock Option (Right to Buy) 2,901 $42.15 $122,277
Option
RONDONI JOHN officer: Chief Technology Officer
Employee Stock Option (Right to Buy) 5,802 $71 $411,942
Sale
MCCORMICK SHAWN director
Common Stock 800 $220 $176,000
Sale
RONDONI JOHN officer: Chief Technology Officer
Common Stock 31 $215 $6,665
Patent
Grant
Filling date: 23 Feb 2021 Issue date: 20 Sep 2022
Grant
Filling date: 23 Feb 2021 Issue date: 20 Sep 2022
Application
Filling date: 12 Feb 2021 Issue date: 8 Sep 2022
Grant
Filling date: 22 May 2019 Issue date: 6 Sep 2022
Application
Filling date: 11 Apr 2022 Issue date: 28 Jul 2022
Application
Filling date: 12 Nov 2021 Issue date: 7 Jul 2022
Grant
Filling date: 1 Jun 2018 Issue date: 14 Jun 2022
Application
Filling date: 11 Jan 2021 Issue date: 26 May 2022
Grant
Filling date: 30 Jun 2021 Issue date: 17 May 2022
Application
Filling date: 25 Jan 2022 Issue date: 12 May 2022
Monday, 23 December 2024
investopedia.com
Thursday, 5 December 2024
businesswire.com
Wednesday, 4 December 2024
zacks.com
zacks.com
Wednesday, 20 November 2024
benzinga.com
Friday, 15 November 2024
globenewswire.com
Monday, 11 November 2024
globenewswire.com
Wednesday, 6 November 2024
globenewswire.com
Tuesday, 5 November 2024
zacks.com
Monday, 4 November 2024
seekingalpha.com
zacks.com
zacks.com
globenewswire.com
Wednesday, 30 October 2024
zacks.com
globenewswire.com
Tuesday, 29 October 2024
zacks.com
Monday, 28 October 2024
zacks.com
Friday, 18 October 2024
zacks.com
Monday, 7 October 2024
globenewswire.com
Friday, 27 September 2024
zacks.com
Wednesday, 18 September 2024
zacks.com
Friday, 6 September 2024
prnewswire.com
Wednesday, 4 September 2024
zacks.com
seekingalpha.com
Monday, 2 September 2024
zacks.com
Wednesday, 21 August 2024
globenewswire.com
Friday, 9 August 2024
zacks.com
Wednesday, 7 August 2024
zacks.com
Tuesday, 6 August 2024
seekingalpha.com
zacks.com
  • What's the price of Inspire Medical Systems stock today?

    One share of Inspire Medical Systems stock can currently be purchased for approximately $90.06.

  • When is Inspire Medical Systems's next earnings date?

    Unfortunately, Inspire Medical Systems's (INSP) next earnings date is currently unknown.

  • Does Inspire Medical Systems pay dividends?

    No, Inspire Medical Systems does not pay dividends.

  • How much money does Inspire Medical Systems make?

    Inspire Medical Systems has a market capitalization of 5.39B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 53.19% to 624.8M US dollars.

  • What is Inspire Medical Systems's stock symbol?

    Inspire Medical Systems, Inc. is traded on the NYSE under the ticker symbol "INSP".

  • What is Inspire Medical Systems's primary industry?

    Company operates in the Healthcare sector and Medical - Devices industry.

  • How do i buy shares of Inspire Medical Systems?

    Shares of Inspire Medical Systems can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Inspire Medical Systems's key executives?

    Inspire Medical Systems's management team includes the following people:

    • Mr. Timothy P. Herbert Chief Executive Officer, Pres & Director(age: 62, pay: $947,370)
    • Mr. Richard J. Buchholz Chief Financial Officer(age: 57, pay: $592,510)
    • Mr. Randall A. Ban Chief Commercial Officer(age: 60, pay: $578,640)
    • Mr. Philip J. Ebeling Chief Operating Officer(age: 54, pay: $487,680)
    • Mr. Steven L. Jandrich Vice President of HR(age: 58, pay: $417,220)
  • How many employees does Inspire Medical Systems have?

    As Jul 2024, Inspire Medical Systems employs 1,011 workers.

  • When Inspire Medical Systems went public?

    Inspire Medical Systems, Inc. is publicly traded company for more then 7 years since IPO on 3 May 2018.

  • What is Inspire Medical Systems's official website?

    The official website for Inspire Medical Systems is inspiresleep.com.

  • Where are Inspire Medical Systems's headquarters?

    Inspire Medical Systems is headquartered at 5500 Wayzata Boulevard, Golden Valley, MN.

  • How can i contact Inspire Medical Systems?

    Inspire Medical Systems's mailing address is 5500 Wayzata Boulevard, Golden Valley, MN and company can be reached via phone at +84 46724357.

  • What is Inspire Medical Systems stock forecast & price target?

    Based on 2 Wall Street analysts` predicted price targets for Inspire Medical Systems in the last 12 months, the avarage price target is $250.67. The average price target represents a 178.33% change from the last price of $90.06.

Inspire Medical Systems company profile:

Inspire Medical Systems, Inc.

inspiresleep.com
Exchange:

NYSE

Full time employees:

1,011

Industry:

Medical - Devices

Sector:

Healthcare

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

5500 Wayzata Boulevard
Golden Valley, MN 55416

CIK: 0001609550
ISIN: US4577301090
CUSIP: 457730109